Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration

Conditions:   Chondrosarcoma;   Osteosarcoma;   Soft Tissue Sarcoma Intervention:   Drug: Abemaciclib Sponsor:   Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials